# Innovation

## Innovations & IPs

- Automated staining protocol for seven-colour immunofluorescence of human and animal tissue sections for diagnostic and prognostic use (TEC-18-96)
- PD-L1 monoclonal antibody as a diagnostic tool to predict anti-PD-L1 and anti-PD-1 immunotherapy response in cancer (IMC/Z/12757)
- IHC staining for CD38 predict anti-PD-1 immunotherapy response (TEC-18-92) and in house engineered antibody (2023-019)
- IHC staining for CD39 predict PD-1/PD-L1 inhibitor immunotherapy response (IMC/Z/11149) and in-house engineered antibody (IMC/Z/13882)
- PD-L2 monoclonal antibody as a diagnostic tool to predict anti-PD-L1 and anti-PD-1 immunotherapy response in cancer (2023-020)
- Methodology for development of a direct multiplex immunohistochemistry prototype kit for CD39 and PD-L1 detection (2023-021)
- 74 Antibodies Optimised for Immunohistochemistry (IHC) (IMC/Z/13562, licensed to ImmunoQs.)
- Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple negative breast cancer: a translational assay compares to conventional IHC (DxD/Z/11878, licensed out to Lucence Diagnostic)
- IHC-based clinical assay for EBC-129 ADC for cancer. (2021-01-11)
- CD8+ T-cell prediction with AI in histological images. (Ref. 2024-021)
- Method for Testing Multiple Tissue Samples on A Single Stereo-seq Spatial Transcriptomics Chip (ASTAR ref Z2024-280; RE 2024-016)
- Blood-based Biomarkers for Lung Cancer (2024-009 - Z2024-158)
- Integrated platform for neoantigen identification using patient derived tumor biopsy (2023-010 - IMC/Z/14352)
- Albumin-based Multifunctional Nanocarriers for Cancer Vaccine Delivery (Z2024-108; PCT/SG2025/050559)
- Whole slide blood smear assay on slides for high throughput protein and cell analysis (Z2024-755)
- Whole slide smear imaging assay for high throughput cell culture analysis (Z2024-825)
- PD-L1-expressing tumour cell prediction on haematoxylin and eosin-stained whole slide images (Z2024-656)
- Low and High Molecular Weight Protein Enrichment (Z2024-690)
- A computer-implemented method for cell-level detection a prediction of cancer biomarker associated features (ref: IP2024-030-01; PCT/SG2025/050432)
- Antibody-drug conjugate target protein expression prediction on haematoxylin and eosin-stained whole slide images (Z2024-655, Licensed to ViewsML.)
- Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans (TD 2025-020, Licensed to Lucence Diagnostics)

---

## Professional Membership

- **Co-founder** World Immunotherapy Council Asian Chapter
- **Co-Chair** World Immunotherapy Council 2019, 2023, 2025
- **Committee Member** of Society of Immunotherapy for Cancer (SITC)
- **Co-founder and Committee Member Clinical Day (CLINICCAI)** of International Conference on Medical Image Computing and Computer Assisted Intervention, **MICCAI**
- **Executive Secretary** of Singapore Society of Oncology â€“ Cancer immunotherapy consortium
- **Education/Diagnostics Co-Lead**, **SingHealth Duke-NUS** Cell Therapy Centre
- **Executive Committee Member**, Singapore Society of Pathology
- **Founder**, Spatial JEDI Council
- **Board & Committee Member**, **Asian Society of Digital Pathology** (ASDP)
- **Board member**, Digital Pathology Special Interest Group, MICCAI
- **Lead & Committee Member** of Society for Immunotherapy for Cancer (SITC)
- **Committee Member**, Cancer Peak, Singapore General Hospital
- **Membership** of United States and Canada Academy of Pathology (USCAP)
- **Fellow** of British Royal College of Pathologist (RCPath)
- **Membership** of Pathology Society of Great Britain and Ireland (SocPath)
- **Membership** of Singaporean Society for Immunology (SgSi)
- **Adjunct Membership** of International Academy of Pathology (IAP) - Singapore Division
- **Membership** of European Society of Pathology
- **NIH Alliance** of Digital Pathology
- **Singapore Biodesign Alumni** (Winner of BEP program 2021)
- **Member Board of Directors**, African & Asian Society of Digital Pathology (ASDP)
- **Board Member**, Medical Image Computing and Computer Assisted Intervention (MICCAI) Society
- **Board Member**, MICCAI Special Interest Group on Computational Pathology
- **Committee member**, American Society of Clinical Oncology (ASCO)
